:
: ...
. , . , , , . . , , . ( ) . : , , , . , , , . , , . (THC) (CBD)
. , , Crohn, , , Parkinson. American College of Physicians (ACP)
2008 . . American College of Physicians THC ( ) , . American
College of Physicians , AIDS (1). , . . THC . . -3 -6 (GLA) 2:5:1.
5% GLA, , . . THC . Rick Simpson, , , . , , . , Simpson. . , , . ,
, ;, . , . Rick Simpson , . . Dr. Robert Ramer Dr. Burkhard Hinz
Rostock (2). Journal of the National Cancer Institute Advance
Access 25 2007 Inhibition of Cancer Cell Invasion by Cannabinoids
via Increased Expression of Tissue Inhibitor of Matrix
Metalloproteinases-1. , , , . , , , , . , 2007 Harvard. , Harvard .
, , , Anju Preet, Ph.D., . CB1 CB2, ( ) THC , . 2004 Cancer
Research, American Association for Cancer Research, (3). Florida
THC . , , Kaposi, Burkitt Hodgkin. 1988, Complutense , THC , . 2000
Nature Medicine THC ( ) . Dr. Manuel Guzman THC (4). Journal of
Pharmacology and Experimental Therapeutics . CBD - , CBD (5). 1974
Virginia. THC , 36% (6). National Institute of Health , THC . DEA
(Drug Enforcement Administration) . 1975 Journal of the National
Cancer Institute Antineoplastic Activity of Cannabinoids ( ) :
Lewis (THC) (CBN) , . 20 THC CBN . , , . . . . 2006 . Dr Wai Man
Liu Queen Marys School of Medicine and Dentistry , (THC), . 70, Run
From The Cure, , . . Rick Simpson . . YouTube . , . , , . Dr.
Robert Melamede : 600 (, , , , , , , , ..) . , . , , , , , 75% 2 5
. , ; .
2008 Emerging Clinical Applications for Cannabis and
Cannabinoids: A Review of the Scientific Literature, 150 , . 30 , .
10 , , (7), (8), (9) (10). 2008 Cannabinoids for Cancer Treatment:
Progress and Promise, (11). 2006 British Journal of Cancer THC
(12). 2008 Expert Review of Neurotherapeutics . , (13). . 20.000 .
. , 2010 University of California Center for Medicinal Cannabis
Research , placebo . . , , , , , , AIDS . . . placebo . 2010 2005
37 2563 . 1970, 80 90 . , , Lou Gehrig). , ( ) ( ). . , , , , , . ,
. . , , (vaporization) . (vaporization) ( 180-190 ), ( 230 ), ( ).
. , . , Institute of Medicine, . Drug Enforcement Administration
(DEA) . Francis L. Young : . . . (Integrative Medicine), , . ; ; ,
; , , . , , . : , , , . , : , . . : , , . , , , , . . , . , , , . :
. , . , , . , . : CB1, , , , , CB2, . , . . , . anandamide
2-arachidonoylglycerol (2-AG). . Delta-9-tetrahydrocannabinol THC ,
cannabidiol (CBD) cannabinol (CBN) . cannabis sativa, , echinacea
purpura, . THC , . . UV, . , . . THC, dronabinol (Marinol) nabilone
(Cesamet), THC, FDA . , . 600 THC. , . , , , . , : ; , , ; . . , .
, . , . . , . . , , THC, , , THC . , , vaporizer . . , , ; . , , .
, . . ( ). 1998 FEBS Letters delta-9-THC ( ) (14). 2000 THC WIN
55,212-2, (15). 2003 (16). , , cannabidiol (CBD), in vivo. 2003
Journal of Pharmacology and Experimental Therapeutics Fast Forward,
: CBD in vitro in vivo, CBD (17). 2004 Guzman (CBM) . 2004 Cancer
Research (18). California Pacific Medical Center Research Institute
THC , WIN 55,212-2. THC , , (19). THC , temozolomide (TMZ) ( )
(20). THC GBM (glioblastoma multiforme). , GBM, THC 9 . THC, , ,
(21). (22-24). 2011 International Society for Pediatric
Neurosurgery (25). , , , , , , , , , , , , , , . Harvard 17 2007 ,
THC, . Harvard THC . THC (26). THC , 50% . 60% . 2007 2010
California Pacific Medical Center Research Institute cannabidiol
(CBD) ID1. , . CBD ID1, (27). , , (28-29). , . , ;35 35 . , , , .
.. 1. 2006 British Journal of Cancer , ( ) . . . , 9 . ( ) . Ki67,
(30).2. 2001 Cancer Research , CB(2) (31).3. 2003 Pharmacology and
Experimental Therapeutics , . : (CBs) . , in vitro ( ) (CBD), , U87
U373., U87 . , (CBD) in vitro () in vivo ( ), () (32).4. 2011
Molecular Cancer Therapeutics temezolomide . : (glioblastoma
multiforme) , . 9- (THC), , , , , , ( ) . (THC) temozolomide ,
temezolomide. temozolomide . (CBD) ( ) ., temezolomide temozolomide
temozolomide . (glioblastoma multiforme) (33).5. 2007 Molecular
Neurobiology . : , Cannabis sativa L., . . , , , , (9)- (THC)
(glioblastoma multiforme). , (34).6. 2005 British Journal of
Pharmacology (35).7. 2007 Journal of Clinical Investigation ER . :
(9)- (THC), , . (36).8. 2004 Journal of Cancer Research : . : , - .
(VEGF) , , . , cDNA VEGF . (ELISA, Western blotting, confocal
microscopy) VEGF VEGF VEGF (VEGFR-2), VEGF, . VEGF . , (9)-
(glioblastoma multiforme) (4 ) VEGF VEGFR-2 . VEGF , (37).. 9. 2010
Pharmacology : . : (9)- (8)- - . (2) Tu183. . : Tu183 (38).. 10.
2011 Breast Cancer Research Treatment , . : . , . , , . Id-1 .
(CBD), , Id-1 . . (39).11. 2011 PLoS One . : CB(1) CB(2) - . , .
CB(2) CXCR4 CXCL12. . CB(2) (40).12. 2006 Journal of Pharmacology
and Experimental Therapeutics - (41).13. 2010 Molecular Cancer
ErbB2 ATK. : ErbB2 . ErbB2, . . , ErbB2. (9)-, , JWH-133, CB2, , /
MMTV-neu. , ( ) . ErbB2 (42).14. 2012 Cancer Treatment Review : ;.
: 1 10 . , . , . . , Cannabis sativa, . -, ( ), - - ., , . - ,
(43).15. 1998 PNAS (44).16. 2006 Journal of Cancer Research (9)-
Cdc2 (45).17. 2000 Endocrinology Trk (46).. 18. 2012 FASEB (Journal
of the Federation of American Societies for Experimental Biology)
-1 (47).19. 2011 Cancer Prevention Research CB1 CB2 (48).20. 2008
Oncogene (9)- in vitro () in vivo ( ) (49).. 21. 2006 Journal of
Cancer Research ( ) . : . , . , . ( ), mRNA p8. . , ( ) TRB3 , .
(50).. 22. 2003 Prostate - : . : (ANA) . - ANA (51).23. 2012 Indian
Journal of Urology . . : - . PubMed , , , . 1 2, , . 1980. 2005
Sarfaraz CB1 CB2 CB1/CB2 WIN-55,212-2 ( ) , PSA, . PSA , , - , , ,
. : CB1 . , , , , , , , , , , , , . , . . (9)- . , Cannabis sativa,
(, - ), . . 20mg (9)- 120mg ( ) (52).24. 2014 British Journal of
Pharmacology -THC in vitro in vivo: (53).. 25. 2012 Journal of
Molecular Medicine - . : , Cannabis sativa ( ) ( ) . - in vivo ( )
(54).26. 2009 Pharmacology Research . : . . -, - . , CB(1) / CB(2)
. (55).27. 2005 Gut , , : - 2 (56).28. 2008 University of Texas, MD
Anderson Cancer Center . : CB1 , Cancer Research. CB1 , . . CB1 , ,
, Raymond DuBois, University of Texas M.D. Anderson Cancer Center.
DuBois Vanderbilt-Ingram Cancer Center CB1 , decitabine. CB1, , .
(ligands) . (Agonists) . - , , DuBois. CB1 (57).. 29. 2006 American
Association of Cancer Research . : . , 30%. , . , Cannabis sativa ,
. (58).. 30. 2002 Blood (59).31. 2006 Molecular Cancer Research
(9)- Jurkat Bad . : , (9)-, ( ) , . (60).32. 2008 International
Journal of Cancer 1 2 non-Hodgkin: (61).. 33. 2003 Journal of
Clinical Investigation (62).. 34. 2011 Cell Death and
Differentiation - : AMPK . : . , . , . , . (9)-, Cannabis sativa,
JWH-015 ( ) HepG2 ( ) HuH-7 ( ), CB(2). . (63).. 35. 2013 American
Urological Association . 10 2013 Medscape . : , . , Kaiser
Permanente 45% , . , , Anil Thomas, Southern California Permanente.
Dr. Thomas 2013 . (, ) Dr. Thomas. . , Dr. Thomas 82.050 Northern
and Southern California Kaiser Permanente, , 2002 2003. 11 , , . .
, ( ) , . , Dr. Thomas. , (64). . ( ), ( ..) ( ). , ! , . , ( , ),
. ( ) . , , . , . !(: . , . , ).
,American Council of Applied Clinical NutritionAmerican
Association of Drugless Practitioners. .
1.http://www.redorbit.com/news/health/1259095/doctor_group_endorses_medical_marijuana/2.
http://salem-news.com/articles/january112008/cancer_treatment_11008.php3.
http://www.eurekalert.org/pub_releases/2004-08/aafc-mii081204.php4.
Pharmacology and Experimental Therapeutics, vol. 299, issue 3,
951-959, December 20015. Massi et al., Antitumor effects of
cannabidiol, a non-psychotropic cannabinoid, on human glioma cell
lines, Journal of Pharmacology and Experimental Therapeutics Fast
Forward, 308, 838-845, 20046.
http://www.alternet.org/drugreporter/20008/7. McAllister S.D.,
Christian R.T., Horowitz M.P., Garcia A., Desprez P.Y., Cannabidiol
as a novel inhibitor of Id-1 gene expression in aggressive breast
cancer cells, Molecular Cancer Therapeutics, November 2007 6,
29218. Preet A., Ganju R.K., Groopman J.E., Tetrahydrocannabinol
inhibits epithelial growth factor-induced lung cancer cell
migration in vitro as well as its growth and metastasis in vivo,
Oncogene, 27, 339-346, 20089. Carracedo A., Gironella M., Lorente
M., Garcia S., Guzman M, Velasco G., Iovanna J., Cannabinoids
Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic
Reticulum StressRelated Genes, Cancer Research, 66, 6748, 200610.
Guzman M., Duarte M.J., Blazquez C., Ravina J., Rosa M.C.,
Galve-Roperh I., Sanchez C., Velasco G., Gonzalez-Feria L., A pilot
clinical study of Delta9-tetrahydrocannabinol in patients with
recurrent glioblastoma multiforme, British Journal of Cancer,
95(2), 197-203, July 200611. Sarfaraz S., Adhami V.M., Syed D.N.,
Afaq F., Mukhtar H., Cannabinoids for Cancer Treatment: Progress
and Promise, Cancer Research, 17, 95,2, January 15, 200812. Guzman
M., Duarte M.J., Blazquez C., Ravina J., Rosa M.C., Galve-Roperh
I., Sanchez C., Velasco G., Gonzalez-Feria L., A pilot clinical
study of Delta9-tetrahydrocannabinol in patients with recurrent
glioblastoma multiforme, British Journal of Cancer, 17, 95,2,
197-203, July 200613. Parolaro D., Massi P., Cannabinoids as
potential new therapy for the treatment of gliomas, Expert Review
of Neurotherapeutics, 8, 1, 37-49, January 200814. Guzman et al.
Delta-9-tetrahydrocannabinol induces apoptosis in C6 glioma cells,
FEBS Letters 436, 6-10, 199815. Guzman et al., Anti-tumoral action
of cannabinoids: involvement of sustained ceramide accumulation and
extracellular signal-regulated kinase activation, Nature Medicine
6, 313-319, 200016. Guzman et al., Inhibition of tumor angiogenesis
by cannabinoids, The FASEB Journal, 17, 529-531, 200317. Massi et
al., Antitumor effects of cannabidiol, a non-psychotropic
cannabiboid, on human glioma cell lines, Journal of Pharmacology
and Experimental Therapeutics Fast Forward, 308, 838-845, 200418.
Guzman et al., Cannabinoids inhibit the vascular endothelial growth
factor pathways in gliomas, Cancer Research, 64, 5617-5623, 200419.
Allister et al., Cannabinoids selectively inhibit proliferation and
induce death of cultured human glioblastoma multiforme cells,
Journal of Neurooncology, 74, 31-40, 200520. Torres et al., A
combined preclinical therapy of cannabinoids and Temozolomide
against glioma, Molecular Cannabis Therapeutics, 10, 90, 201121.
Guzman et al., A pilot clinical study of
delta-9-tetrahydrocannabinol in patients with recurrent
glioblastoma multiforme, British Journal of Cancer, 200622.
Parolaro, Massi, Cannabinoids as a potential new drug therapy for
the treatment of gliomas, Expert Reviews of Neurotherapeutics, 8,
37-49, 200823. Galanti et al., Delta9-Tetrahydrocannabinol inhibits
cell cycle progression by downregulation of E2F1 in human
glioblastoma multiforme cells, Acta Oncologica, 12, 1-9, 200724.
Calatozzolo et al., Expression of cannabinoid receptors and
neurotrophins in human gliomas, Neurological Sciences, 28, 304-310,
200725. Foroughi et al., Spontaneous regression of septum
pellucidum/forniceal pilocytic astrocytomas possible role of
cannabis inhalation, Childs Nervous System, 27, 671-679, 201126.
Science Daily, Apr. 17, 200727. McAlister SD, Christian R.T.,
Horowitz M.P., Garcia A., Desprez P.Y., Cannabidiol as a novel
inhibitor of Id-1 gene expression in aggressive breast cancer
cells, 6, 11, 2921-7, Molecular Cancer Therapeutics, 200728.
Natalya Kogan, Canabiboids and cancer, Mini-Reviews in Medicinal
Chemistry, 5, 941-952, 200529. Sarafaraz et al., Cannabinoids for
cancer treatment: progress and promise, Cancer Research, 68,
339-342, 200830. Guzman M., et al., A pilot clinical study of
9-tetrahydrocannabinol in patients with recurrent glioblastoma
multiforme British Journal of Cancer, 95, 197-203, 200631. Sanchez
C., et al., Inhibition of glioma growth in vivo by selective
activation of the CB(2) cannabinoid receptor, Cancer Res,
61(15):5784-9, 200132. Massi P., et al., Antitumor effects of
cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell
lines, The Journal of Pharmacology and Experimental Therapeutics,
308, 3, 838-845, 200433. Torres S., et al., A combined preclinical
therapy of cannabinoids and temozolomide against glioma, Molecular
Cancer Therapeutics, 10, 90, 201134. Velasco G., et al.,
Cannabinoids and gliomas, Mol. Neurobiol., 36(1):60-7, 200735.
Vaccani A., et al., Cannabidiol inhibits human glioma cell
migration through a cannabinoid receptor-independent mechanism,
British Journal of Pharmacology, 144(8):1032-1036, 200536. Salazar
M., et al., Cannabinoid action induces autophagy-mediated cell
death through stimulation of ER stress in human glioma cells,
Journal of Clinical Investigation, 119(5):1359-1372, 200937.
Blazquez C., et al., Cannabinoids inhibit the vascular endothelial
growth factor pathway in gliomas, Cancer Res, 64:5617, 200438.
Whyte D.A., et al., Cannabinoids inhibit cellular respiration of
human oral cancer cells, 85(6): 328-35, 201039. McAllister S.D., et
al., Pathways mediating the effects of cannabidiol on the reduction
of breast cancer cell proliferation, invasion, and metastasia,
Breast Cancer Res Treat, 129(1):37-47, 201140. Nasser M.V., et al.,
Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor
CB2 in modulating breast cancer growth and invasion, PLoS One,
6(9):e23901, 201141. Ligresti A., et al., Anti-tumor activity of
plant cannabinoids with emphasis on the effect of cannabidiol on
human breast carcinoma, Journal of Pharmacology and Experimental
Therapeutics, 200642. Caffarel M., et al., Cannabinoids reduce
ErbB2-driven breast cancer progression through Akt inhibition,
Molecular Cancer, 9:196, 201043. Caffarel M.M., et al.,
Cannabinoids: a new hope for breast cancer therapy;, Cancer
Treatment Rev, 38(7):911-8, 201244. Petrocellis L., et al., The
endogenous cannabinoid anandamide inhibits human breast cancer cell
proliferation, PNAS, 95, 8375-8380, 199845. Caffarel M., et al.,
(9)-Tetrahydrocannabinol inhibits cell cycle progression in human
breast cancer cells through Cdc2 regulation, Cancer Res, 66:6615,
200646. Melch D., et al., Suppression of nerve growth factor Trk
receptors and prolactin receptors by endocannabinoids leads to
inhibition of human breast and prostate cancer cell proliferation,
141, 1, 200047. Ramer R., et al., Cannabidiol inhibits lung cancer
cell invasion and metastasis via intercellular adhesion molecule-1,
FASEB J, 26(4):1535-48, 201248. Preet A., et al., Cannabinoid
receptors, CB1 and CB2, as novel targets for inhibition of
non-small cell lung cancer growth and metastasis, Cancer Prev Res,
4(1):65-75, 201049. Preet A., (9)-Tetrahydrocannabinol inhibits
epithelial growth factor-induced ling cancer cell migration in
vitro as well as its growth and metastasis in vivo, Oncogene, 27,
339-346, 200850. Carracedo A., et al., Cannabinoids induce
apoptosis of pancreatic tumor cells via endoplasmic reticulum
stress-related genes, Cancer Res, 66;6748, 200651. Mimeault M., et
al. Anti-proliferative and apoptotic effects of anandamide in human
prostatic cancer cell lines: implication of epidermal growth factor
receptor down-regulation and ceramide production, Prostate,
15;56(1):1-12, 200352. Ramos J.A., Bianco F.J., The role of
cannabinoids in prostate cancer: Basic science perspective and
potential clinical applications, Indian Journal of Urology, 28(1):
9-14, 201253. De Petrocellis L., et al., Non-THC cannabinoids
inhibit prostate carcinoma growth in vitro and in vivo:
pro-apoptotic effects and underlying mechanisms, Br J Pharmacolol,
168(1):79-102, 201354. Aviello G., et al., Chemopreventive effect
of the non-psychotropic phytocannabinoid cannabidiol on
experimental colon cancer, J Mol Med, 90(8):925-34, 201255. Izzo
A.A., Camilleri M., Cannabinoids in intestinal inflammation and
cancer, 60(2):117-25, 200956. Patsos H.A., et al., The endogenous
cannabinoid, anandamide, induces cell death in colorectal carcinoma
cells: a possible role for cyclooxygenase 2, Gut, 54:1741-1750,
200557. The University of Texas, MD Anderson Cancer Center,
Turned-off cannabinoid receptor turns on colorectal tumor growth,
200858. Afaq F., et al., Cannabinoid receptors as a target for
therapy of ovarian cancer, American Association Cancer Research,
47, 200659. McKallip R.J., et al., Targeting CB2 cannabinoid
receptors as a novel therapy to treat malignant lymphoblastic
disease, Blood, 100(2):627-34, 200260. Jia W., et al.,
Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T
cells is regulated by translocation of Bad to mitochondria, Mol
Cancer Res, 4(8):549-62, 200661. Gustafsson K., et al., Expression
of cannabonoid receptors type 1 and type 2 in non-Hpdgkin lymphoma:
Growth inhibition by receptor activation, International Journal of
Cancer, 123, 5, 1025-1033, 200862. Casanova M.L., et al.,
Inhibition of skin tumor growth and angiogenesis in vivo by
activation of cannabinoid receptors, J Clin Invest, 111(1):43-50
200363. Vara D., et al., Anti-tumoral action of cannabinoids on
hepatocellular carcinoma: role of AMPK-dependent activation of
autophagy, Cell Death Differ, 18(7):1099-111, 2011
::
...http://thesecretrealtruth.blogspot.com/2015/04/blog-post_97.html#ixzz3WSQEsKCC
